by Eric Christianson | Mar 17, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Respiratory Medication and Disease State Clinical Pearls
Most often, breathing difficulties are due to a chronic disease process like asthma or COPD. These are obvious possible diagnoses for any patient presenting with respiratory concerns. If you are a healthcare professional, you must recognize that there are a...
by Eric Christianson | Mar 3, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Statins are one of the most commonly prescribed medications to help reduce cholesterol and reduce the risk of cardiovascular events like heart attack and stroke. I’ve been asked the question a few different times about why we should choose a hydrophilic versus a...
by Eric Christianson | Dec 26, 2018 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Orthostasis risk with SGLT-2 Inhibitors is a potential minor concern, particularly in our geriatric population. While a drop in blood pressure can be a good thing for a significant chunk of diabetes patients, that potential modest drop can lead to an increased...
by Eric Christianson | Dec 5, 2018 | Medication and Disease State Clinical Pearls For Pharmacists, Respiratory Medication and Disease State Clinical Pearls
Patient adherence is not the sexiest topic on the planet, but you must understand how prevalent this problem is. You can be the smartest clinician on the planet and select the most appropriate medication for your patient every time, but does it really matter if they...
by Eric Christianson | Nov 25, 2018 | Cardiovascular Medication and Disease State Clinical Pearls, Drug Interaction Case Studies and Education For Pharmacists, Medication and Disease State Clinical Pearls For Pharmacists
Apixaban (Eliquis) is a somewhat newer anticoagulant. While it is tempting to utilize the “set it and forget it” mindset with dosing, we must remember that there are a few reasons that we might have to make apixaban dose adjustments. Apixaban dose...
by Eric Christianson | Nov 14, 2018 | Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Today I’m going to discuss a case involving a patient concern with inappropriate production of milk (formally known as galactorrhea). Keep an eye at the end of this post for some MAJOR announcements about upcoming content releases! For now, here’s the...